Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Short Term Outcomes After PRoton and PhotoN RadiOtherapy for IDH Mutated Grade 2 and 3 Gliomas

NCT06180434 is registered in ClinicalTrials.gov with Erasmus Medical Center as lead sponsor.

NCT NCT06180434
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06180434 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Short Term Outcomes After PRoton and PhotoN RadiOtherapy for IDH Mutated Grade 2 and 3 Gliomas
Lead sponsor
Erasmus Medical Center
Phase
Observational
Overall status
Recruiting
Start date
May 1, 2024
Completion date
November 1, 2025
Enrollment
320 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

glioma, radiotherapy; complications